Trial Profile
An observational study evaluating relationships between meloxicam dose and risks of gastrointestinal (GI), cardiovascular (CV), and renal events in patients with osteoarthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Jan 2017
Price :
$35
*
At a glance
- Drugs Meloxicam (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions
- 25 Jan 2017 New trial record